Catheter Precision Inc. (AMEX: VTAK) is -77.37% lower on its value in year-to-date trading and has touched a low of $0.31 and a high of $8.40 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The VTAK stock was last observed hovering at around $0.91 in the last trading session, with the day’s gains setting it 0.01%.
Currently trading at $0.92, the stock is 106.94% and 13.23% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 8.51 million and changing 0.55% at the moment leaves the stock -74.78% off its SMA200. VTAK registered -75.83% loss for a year compared to 6-month loss of -79.44%. The firm has a 50-day simple moving average (SMA 50) of $0.8084 and a 200-day simple moving average (SMA200) of $3.6291.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 103.33% gain in the last 1 month and extending the period to 3 months gives it a -59.33%, and is 161.43% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 36.17% over the week and 17.70% over the month.
Catheter Precision Inc. (VTAK) has around 14 employees, a market worth around $2.56M and $0.44M in sales. Profit margin for the company is -2176.83%. Distance from 52-week low is 194.02% and -89.11% from its 52-week high. The company has generated returns on investments over the last 12 months (-41.37%).
with sales reaching $1.06M over the same period., but quarterly earnings will post 621.70% year-over-year. Quarterly sales are estimated to grow 697.00% in year-over-year returns.
Catheter Precision Inc. (VTAK) Top Institutional Holders
13.0 institutions hold shares in Catheter Precision Inc. (VTAK), with institutional investors hold 3.04% of the company’s shares. The shares outstanding are 2.80M, and float is at 2.41M with Short Float at 1.93%. Institutions hold 2.53% of the Float.
Catheter Precision Inc. (VTAK) Insider Activity
The most recent transaction is an insider purchase by JENKINS DAVID A, the company’s Executive Chairman and CEO. SEC filings show that JENKINS DAVID A bought 9,528 shares of the company’s common stock on Jan 23 ’24 at a price of $0.60 per share for a total of $5694.0. Following the purchase, the insider now owns 0.33 million shares.
Catheter Precision Inc. disclosed in a document filed with the SEC on Jan 22 ’24 that JENKINS DAVID A (Executive Chairman and CEO) bought a total of 9,528 shares of the company’s common stock. The trade occurred on Jan 22 ’24 and was made at $0.43 per share for $4092.0. Following the transaction, the insider now directly holds 0.32 million shares of the VTAK stock.
Still, SEC filings show that on Jan 19 ’24, JENKINS DAVID A (Executive Chairman and CEO) acquired 8,470 shares at an average price of $0.42 for $3595.0. The insider now directly holds 310,800 shares of Catheter Precision Inc. (VTAK).
